Stock SLRN ACELYRIN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Acelyrin, Inc.

Equities

SLRN

US00445A1007

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
4.13 USD -2.13% Intraday chart for Acelyrin, Inc. -5.92% -44.64%
May. 22 HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating MT
May. 09 Acelyrin, Inc. Announces Ron Oyston to Step Down as Chief People Officer, Effective August 15, 2024 CI

Evolution of the average Target Price on Acelyrin, Inc.

Price target over the last 5 years

History of analyst recommendation changes

50e2e3.ZV8NvHgxXMlyFyYVIni613va3MTPway5QfQ6RKu9K0k.LRMg7jpmbJNGbmgjU0zsui2e5bT6pvvUJZ1pCt_6bR82EVTzCmkb_hRtQQ~149ebad189e575212898507877414b65

Analyst Recommendations on Acelyrin, Inc.

HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating MT
Wells Fargo Raises ACELYRIN's Price Target to $13 From $11, Keeps Equalweight Rating MT
Wells Fargo Starts Coverage on ACELYRIN with Equalweight Rating, $11 Price Target MT
Citigroup Initiates ACELYRIN at Neutral Rating With $8 Price Target MT
Morgan Stanley Adjusts Price Target on ACELYRIN to $13 From $19, Maintains Equal-Weight Rating MT
Jefferies Adjusts ACELYRIN Price Target to $12 From $15, Maintains Buy Rating MT
Morgan Stanley Downgrades ACELYRIN to Equalweight From Overweight, Cuts Price Target to $19 From $39 MT
Morgan Stanley Adjusts Price Target on Acelyrin to $39 From $29, Maintains Overweight Rating MT
HC Wainwright Starts Acelyrin at Buy, $44 Price Target MT
Morgan Stanley Initiates Coverage on Acelyrin With Overweight Rating, $29 Price Target MT
Jefferies Starts Acelyrin at Buy With $31 Price Target MT
Piper Sandler Initiates Acelyrin at Overweight With $68 Price Target MT
TD Cowen Starts Acelyrin at Outperform MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
4.13 USD
Average target price
22.17 USD
Spread / Average Target
+436.72%
High Price Target
68 USD
Spread / Highest target
+1,546.49%
Low Price Target
8 USD
Spread / Lowest Target
+93.70%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Acelyrin, Inc.

HC Wainwright
Wells Fargo Securities
Citigroup
Morgan Stanley
Jefferies & Co.
TD Cowen
Piper Sandler

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SLRN Stock
  4. Consensus Acelyrin, Inc.